Cancer News and Research

Latest Cancer News and Research

European disparities in access to cancer drugs

New research has highlighted stark disparities in access to the latest cancer drugs across European Union nations, according to data presented at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm.

15 Sep 2008

Scientists identify kidney failure susceptibility gene

Scientists at Johns Hopkins schools of Public Health and Medicine have, for the first time, identified variants in the gene MYH9 that are associated with increased risk for non-diabetic end stage renal disease (ESRD,) which is the near-loss of kidney function leading to either dialysis of transplant. MYH9, located on the 22 chromosome, is the first gene identified for common forms of kidney disease.

15 Sep 2008

More prostate cancer but fewer deaths

A major study by researchers from the Cancer Council Australia has found that even though more men are being diagnosed with prostate cancer, fewer are dying from the disease.

15 Sep 2008

Investigational drug shows promise in ovarian cancer

An investigational drug that combats ovarian cancer by inhibiting the formation of new blood vessels has shown promise in a phase II trial, according to a presentation at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm.

15 Sep 2008

DNA vaccine developed at the Karmanos Cancer Institute fights HER2-positive cancers

Researchers at the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine have developed a HER2 DNA vaccine that has shown to be effective on drug resistant tumors in mice. The study was reported in the September 15 issue of Cancer Research, a journal of the American Association for Cancer Research.

15 Sep 2008

Adding Taxotere to chemotherapy regimen improves survival in early breast cancer

For patients with early stage breast cancer that has spread to the lymph nodes, adding four cycles of docetaxel (Taxotere) into a sequential regimen of epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) reduces the risk of recurrence and death, updated long-term results show.

15 Sep 2008

Inovio Biomedical achieves 75% complete response rate in preclinical testing of DNA-based cancer vaccine using its electroporation DNA delivery system

Inovio Biomedical Corporation announced today that it achieved positive results from its proprietary research and development program for DNA-based cancer vaccines delivered using the company's electroporation-based DNA delivery technology.

15 Sep 2008

Significant benefits in non-small-cell lung cancer from customizing erlotinib treatment

Lung cancer patients whose tumors carry specific genetic mutations can achieve significantly longer survival when treated with targeted therapies such as erlotinib, Spanish researchers report.

15 Sep 2008

Scientists discover common variants in the human genome conferring risk of bladder cancer

Scientists at deCODE genetics and colleagues at Radboud University Medical Center in the Netherlands today report the discovery of two common single-letter variants in the human genome (SNPs) that confer increased risk of urinary bladder cancer.

14 Sep 2008

Domainex has core intellectual property rights granted for Europe

Domainex Ltd (Domainex), an innovative biopharmaceutical company, today announced the grant of European Patent No.1442134 for its Combinatorial Domain Hunting (CDH) Technology.

From Domainex 14 Sep 2008

Surveillance mammography after treatment for primary breast cancer

The National Institute for Health Research Health Technology Assessment (NIHR HTA) programme has commissioned a new study to identify the most effective and efficient surveillance methods for women who have received treatment for primary breast cancer.

14 Sep 2008

Anti-inflammatory drugs may mask prostate cancer marker

Regular use of nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin and ibuprofen, may reduce serum levels of the prostate biomarker, PSA (prostate specific antigen), and hence may alter the detection of prostate cancer in individuals who take these medications.

14 Sep 2008

FDA approves expanded uses for Gardasil for vaginal and vulvar cancer caused by HPV

The U.S. Food and Drug Administration has announced the approval of the vaccine Gardasil for the prevention of vaginal and vulvar cancer caused by Human Papillomavirus (HPV) types 16 and 18 in girls and women ages 9 to 26.

14 Sep 2008

Accelr8 announces publication of study on OptiChem bio-coatings

Accelr8 Technology Corporation announced today that two teams of university research collaborators report new methods for scalable production with the company’s patented OptiChem bio-coatings.

11 Sep 2008

Scientists discover how to isolate cancer stem cells in tumors

After years of working toward this goal, scientists at the OU Cancer Institute have found a way to isolate cancer stem cells in tumors so they can target the cells and kill them, keeping cancer from returning.

11 Sep 2008

Scientists develop nanometer-sized 'cargo ships' to target and destroy tumors

Scientists have developed nanometer-sized 'cargo ships' that can sail throughout the body via the bloodstream without immediate detection from the body's immune radar system and ferry their cargo of anti-cancer drugs and markers into tumors that might otherwise go untreated or undetected.

11 Sep 2008

Untapped potential of antidepressants for cancer

A comprehensive review of current scientific literature, published in the peer-reviewed journal ecancer, has suggested that antidepressants can help the human body fight cancer by boosting its own immune response, amongst other mechanisms.

11 Sep 2008

Risk of breast cancer mutations underestimated for Asian women, Stanford study shows

Oncologist Allison Kurian, MD, and her colleagues at the Stanford University School of Medicine were perplexed. Computer models designed to identify women who might have dangerous genetic mutations that increase their risk of breast and ovarian cancer worked well for white women. But they seemed to be less reliable for another ethnic group.

11 Sep 2008

New ependymoma genes identified

Scientists have isolated three important genes involved in the development of a type of childhood brain cancer- reveals a study published in the British Journal of Cancer.

10 Sep 2008

Radiation treatment less likely for African American women fighting breast cancer

According to a new study, African American women with breast cancer who have a lumpectomy are less likely to receive radiation treatment compared to white women-the standard for early stage breast cancer.

10 Sep 2008

Cancer News and Research

Latest Cancer News and Research

European disparities in access to cancer drugs

Scientists identify kidney failure susceptibility gene

More prostate cancer but fewer deaths

Investigational drug shows promise in ovarian cancer

DNA vaccine developed at the Karmanos Cancer Institute fights HER2-positive cancers

Adding Taxotere to chemotherapy regimen improves survival in early breast cancer

Inovio Biomedical achieves 75% complete response rate in preclinical testing of DNA-based cancer vaccine using its electroporation DNA delivery system

Significant benefits in non-small-cell lung cancer from customizing erlotinib treatment

Scientists discover common variants in the human genome conferring risk of bladder cancer

Domainex has core intellectual property rights granted for Europe

Surveillance mammography after treatment for primary breast cancer

Anti-inflammatory drugs may mask prostate cancer marker

FDA approves expanded uses for Gardasil for vaginal and vulvar cancer caused by HPV

Accelr8 announces publication of study on OptiChem bio-coatings

Scientists discover how to isolate cancer stem cells in tumors

Scientists develop nanometer-sized 'cargo ships' to target and destroy tumors

Untapped potential of antidepressants for cancer

Risk of breast cancer mutations underestimated for Asian women, Stanford study shows

New ependymoma genes identified

Radiation treatment less likely for African American women fighting breast cancer

Understanding the DNA Damage Response in Innate Immunity eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in